Dr. Biest is Assistant Professor, Department of Obstetrics and Gynecology, and Director, Division of Minimally Invasive Gynecology, Washington University School of Medicine in St Louis, Missouri.
Dr. Mutch is Ira C. and Judith Gall Professor of Obstetrics and Gynecology and Chief of Gynecologic Oncology at Washington University School of Medicine in St. Louis. He serves on the OBG Management Board of Editors.
The authors report no financial relationships relevant to this article.
Now the containment bag with the remaining specimen may be removed through the umbilicus, while simultaneously removing the balloon-tip trocar from the bag.
A safe minimally invasive approach This technique has allowed us to safely remove specimens larger than 1,500 g while keeping them in a contained environment with no spill of tissue within the abdomen.
Tracking and adaptation needed The FDA safety communication has severely limited the practice of morcellation in the minimally invasive gynecologic surgical setting. Many hospitals around the country have reacted by placing significant restrictions on the use of EMM or banned it outright. This action may reverse the national trend of increasing rates of laparoscopic hysterectomy and force many practitioners to return to open surgery.
Currently, it is unclear what the true risk of tissue extraction is whether it is performed via EMM or manually. Large national databases including the BOLD database from the Surgical Review Corporation, as well as AAGL, must be utilized to track these cases and their outcomes to guide therapy. In the meantime, in order to continue to offer a minimally invasive approach to gynecologic surgery, new techniques and instrumentation in the operating room will need to be modified to adapt to these new guidelines. This is vital to maintain or even reduce the rates of open hysterectomy and associated morbidity while diminishing the potential risks of inadvertent benign as well as malignant tissue dispersion with tissue extraction.